Allergic Bronchopulmonary Aspergillosis

Overview

4.8 out of 5 (117 Reviews)

Credits

1.50

Post-Assessment Questions

7

Start Date

1 Sep 2023

Last Review Date

27 Mar 2026

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6279 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7486.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$73.50 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$649 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Allergic bronchopulmonary aspergillosis (ABPA) is an immune-mediated pulmonary disorder caused by hypersensitivity to Aspergillus fumigatus colonizing the airways. The condition most commonly affects individuals with asthma or cystic fibrosis and frequently presents as worsening respiratory symptoms that resemble uncontrolled asthma or recurrent pulmonary exacerbations. Pathophysiology involves an exaggerated T helper type 2 inflammatory response with elevated total and Aspergillus-specific immunoglobulin E (IgE), peripheral eosinophilia, mucus plugging, and central bronchiectasis. Clinical manifestations may include wheezing, productive cough with brown mucus plugs, transient pulmonary infiltrates, and progressive decline in lung function. Delayed recognition can lead to chronic airway inflammation, irreversible bronchiectasis, pulmonary fibrosis, and long-term respiratory impairment.

Participants in this educational activity strengthen competence in identifying individuals at risk for allergic bronchopulmonary aspergillosis and applying contemporary diagnostic criteria. Content emphasizes the interpretation of immunologic testing, imaging findings, and clinical features that distinguish ABPA from asthma with fungal sensitization, eosinophilic lung disease, and chronic pulmonary aspergillosis. Learners evaluate evidence-based treatment approaches, including systemic corticosteroids, antifungal therapy, and biologic agents, while monitoring total IgE levels and clinical response to guide therapy. Collaboration with an interprofessional team that includes clinicians, pulmonologists, pharmacists, nurses, and respiratory therapists supports comprehensive disease monitoring, early relapse detection, and improved long-term respiratory outcomes.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Differentiate immunologic and radiographic findings characteristic of allergic bronchopulmonary aspergillosis, including elevated total and Aspergillus-specific immunoglobulin E levels, eosinophilia, mucus plugging, and central bronchiectasis.

  • Screen patients with persistent asthma symptoms or cystic fibrosis–related pulmonary exacerbations for clinical and laboratory features suggestive of allergic bronchopulmonary aspergillosis.

  • Assess clinical history, symptom patterns, pulmonary function changes, and radiographic findings that raise suspicion for allergic bronchopulmonary aspergillosis in patients with difficult-to-control respiratory disease.

  • Develop effective communication and collaboration practices with the interprofessional healthcare team, including clinicians, pulmonologists, pharmacists, nurses, and respiratory therapists, to coordinate comprehensive care and optimize outcomes for patients with allergic bronchopulmonary aspergillosis.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physicians and Physician Associates: StatPearls, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)TM. Physicians and PAs should only claim credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pathology: Successful completion of this Continuing Certification activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Lifelong Learning (CME) credits in the American Board of Pathology’s Continuing Certification Program.

American Board of Pediatrics: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.50 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Surgery: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Royal College of Physicians and Surgeons of Canada: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Deborah Z. on 2/22/2021

Henrik H. on 4/19/2021

Erica O. on 9/11/2021

Elaine N. on 1/14/2022

Dr. Mallikarjuna S. on 2/18/2022

Jamie H. on 7/1/2022

Kaitlin C. on 8/7/2022

Carrie H. on 11/2/2022

Dr.NIRMALA M. on 11/1/2022

Alida A. on 10/31/2022

Constance J. on 12/8/2022

Ravi J. on 1/2/2023

Meredith K. on 2/14/2023

Dariush O. on 3/1/2023

Pat A. on 3/27/2023

larry m. on 4/4/2023

Maaz A. on 5/1/2023

Yasmeen G. on 5/31/2023

Nithya P. on 7/12/2023

A B. on 9/19/2023

Reena R. on 9/25/2023

Dr Mekham M. on 9/22/2023

Bwayne M. on 10/3/2023

Jack L. on 10/7/2023

Dr Sruthi G. on 10/10/2023

Nizar N. on 11/5/2023

Juan H. on 11/6/2023

Katherine H. on 11/22/2023

Tarik H. on 11/25/2023

unnikrishnan t. on 12/4/2023

makondo s. on 12/5/2023

Jenna P. on 12/8/2023

ROBERT M. on 12/14/2023

Linda G. on 12/14/2023

Felix M. on 12/18/2023

Ronald F. on 12/30/2023

Qefli N. on 1/7/2024

NISHA N. on 1/13/2024

Kerry W. on 1/31/2024

Archaka S. on 2/9/2024

Thomas C. on 2/16/2024

Rosana K. on 2/18/2024

Aimen U. on 2/20/2024

Alexander H. on 2/20/2024

Yongmei J. on 2/20/2024

Giulio R. on 2/22/2024

Eric F. on 2/29/2024

Patrick C. on 3/14/2024

Nithya P. on 3/16/2024

Ricardo Q. on 3/16/2024

Alan S. on 3/21/2024

Keenan H. on 3/24/2024

Timothy b. on 4/2/2024

James s. on 4/7/2024

shahid m. on 4/21/2024

Tara G. on 4/28/2024

Ronald G. on 4/30/2024

Kaman C. on 5/2/2024

Christine G. on 5/13/2024

William N. on 5/19/2024

ishvar p. on 5/20/2024

Wissam A. on 5/21/2024

Aneesh M. on 5/27/2024

Dr ambrish P. on 6/2/2024

Teresa M. on 6/7/2024

Elisa S. on 6/28/2024

Mark M. on 7/6/2024

Kumble R. on 7/11/2024

marc l. on 7/18/2024

Alison G. on 7/20/2024

Paul D. on 7/26/2024

JOEL C. on 8/20/2024

Reza M. on 8/21/2024

Fadi S. on 8/25/2024

Steven B. on 9/12/2024

Martin L. on 9/12/2024

faheem b. on 9/28/2024

Shannan P. on 10/21/2024

Manuel M. on 10/30/2024

leonard o. on 11/5/2024

Stephen N. on 11/5/2024

Excellent review of allergic bronchial aspergillosis.

Louis M. on 11/20/2024

Sriram P. on 11/26/2024

Mohamed E. on 11/27/2024

Cedric B. on 12/4/2024

Danah G. on 12/6/2024

Raymond J. on 12/16/2024

Keith Y. on 12/19/2024

Jeffrey L. on 12/28/2024

Julianna P. on 12/31/2024

Maria R. on 12/31/2024

Meghna R. on 1/7/2025

jae yong l. on 1/12/2025

Nicole M. on 1/20/2025

Ricardo L. on 2/4/2025

Fadi S. on 2/7/2025

K Naras B. on 4/11/2025

Sneha S. on 4/21/2025

Saema M. on 6/5/2025

Bobby S. on 6/18/2025

Erin C. on 6/25/2025

RAVINDRAKUMAR N M. on 7/23/2025

Restituto m. on 9/26/2025

Martin L. on 10/16/2025

Divin K. on 10/27/2025

Monica L. on 11/3/2025

Sharafiya P. on 12/5/2025

pushpalatha A. on 12/14/2025

Christine G. on 12/15/2025

OLUWATOYIN A. on 1/9/2026

Oksana G. on 1/19/2026

Sharafiya P. on 3/26/2026

eric k. on 5/16/2026

Jamil A. on 5/20/2026

Timothy b. on 6/8/2026

shyam b. on 6/18/2026

James S. on 8/18/2026

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6279 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7486.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$73.50 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$649 per 1 year per user